Alexander Douglas | Associate Professor
University of Oxford
Sandy trained clinically as a pharmaceutical physician. He leads a research group at the University of Oxford with interests in vaccine manufacturing and in translational development of novel vaccines, including against rabies & Epstein Barr virus
Appearances:
Day 2 - Wednesday 15th October @ 15:30
Immunogenicity of a single-dose adenovirus-vectored rabies vaccine in a Phase Ib/II clinical trial
last published: 16/Sep/25 16:05 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events